Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
SLOUGH, England and RICHMOND, Va., May 25, 2018 -- (Healthcare Sales & Marketing Network) -- Indivior PLC (LON: INDV) today announced that it has filed a regulatory submission with Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE™ (bupreno... Biopharmaceuticals, Drug Delivery, Regulatory Indivior, SUBLOCADE, buprenorphine, opioid use disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

7 medtech stories we missed this week: May 25, 2018
[Image from unsplash.com]From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance for its Celivizio 100 series F400 and F800 with new Confocal Miniprobe, the CranioFlex. The clearance allows the device to be used during neurosurgical procedures. The Cellvizio 100 with CranioFlex gives allows for imaging of tissue internal microstructures a...
Source: Mass Device - May 25, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Imaging Implants Patient Monitoring Regulatory/Compliance Bonesupport collagenmatrix crossroadsextremitysystems Implanet Mauna Kea Technologies MC10 Medacta xablec Source Type: news

Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
VANCOUVER, May 25, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, t... Devices, Interventional, Cardiology Neovasc, Tiara, Neovasc Reducer, angina pectoris, refractory angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

Pulmonx Closing in On Approval for Valve to Treat Emphysema
Pulmonx has some additional ammunition in its bid to get its severe emphysema treatment valve FDA approval. The Redwood City, CA-based company released positive one-year-results from the LIBERATE pivotal trial of the Zephyr Endobronchial Valve, which shows the study met all primary and secondary endpoints in treating emphysema patients. Emphysema falls under the umbrella of chronic obstructive pulmonary disease (COPD) and is characterized by damage to the walls of the lungs between the air sacs, according to the National Emphysema Foundation. This damage causes the sacs to lose their shape and often, the destruction of tho...
Source: MDDI - May 25, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

FDA permits marketing of artificial intelligence algorithm for aiding providers in detecting wrist fractures
(Source: Food and Drug Administration)
Source: Food and Drug Administration - May 24, 2018 Category: American Health Source Type: news

Former P & G executive to help guide marijuana firm
Former Procter& Gamble Co. executive Peter McDonough has been named a director of Empower Clinics Inc., an owner and operator of medical marijuana clinics. McDonough, who most recently was president of Diageo North America, rose to be a vice president of European marketing within P&G ’s Gillette razor division during a 15-year career with the Cincinnati-based maker of consumer goods (NYSE: PG).  From 2004 to 2006, he oversaw the Duracell battery and Braun appliance brands for the European region,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 24, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
AMSTERDAM, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- BioGX B.V. continues its *BD MAX™ menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX™ Sample-to-Answer platform.... Diagnostics, Product Launch BioGX, BD , meningitis, vancomycin resistance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
Teleflex will acquire the Company's commercial coronary products and an option to purchase the drug coated Chocolate Heart(TM) SINGAPORE, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- QT Vascular Ltd., ("QT Vascular", and with its... Devices, Interventional, Cardiology, Acquisitions QT Vascular, Chocolate XD, Glider , Chocolate Heart, balloon catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

PiCSO therapy reduces infarct size in STEMI patients
Miracor Medical announces new publication at EuroPCR AWANS, Belgium, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Miracor Medical SA announced today the clinical results from the physician-sponsored OxAMI-PiCSO study were published in the ... Devices, Interventional, Cardiology Miracor Medical, OxAMI-PiCSO study, PiCSO Impulse System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Dr. David Tuck, CMO, to retire and return to academia LEXINGTON, Mass., May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and eff... Biopharmaceuticals, Oncology, Personnel Curis , fimepinostat (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO
SAN DIEGO, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Calidi Biotherapeutics, Inc., formerly StemImmune, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announ... Biopharmaceuticals, Oncology, Personnel Calidi Biotherapeutics, StemImmune, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

FDA Warns About Pills That Claim To Protect You From Sun
BOSTON (CBS) – The FDA is sending warning letters to four dietary supplement makers that are marketing tablets and capsules claiming to be a substitute for sunscreen. Skin cancer is the most common cancer in the united states and there’s a direct link between skin cancer and exposure to UV light. The FDA says some companies are misleading consumers by claiming that taking a daily supplement will offer protection against sun damage. The Agency says there is no credible science to back up their claims and these companies are giving people a false sense of security. (Source: WBZ-TV - Breaking News, Weather and Sp...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 23, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated Local Dr. Mallika Marshall FDA Sunscreen Source Type: news

Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study
This study was the largest, longest study to use a less-invasive or minimally-invasive technique using these one-way valves,” Dr. Criner said. Dr. Criner said that after one year, patients treated with the Zephyr valves were significnatly more likely to show improvements in lung function, measured as forced expiratory volume in one second, or FEV1. “Patients that were treated had about a three times greater likelihood of having significant improvement in FEV1, more than 15% in 45% of the treated group compared to 11% of the control,” Dr. Criner said. Additionally, patients treated with the Zephyr reported...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory Pulmonx Source Type: news

OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform to transform the way patients are managed in the ICU,” Vance, who led Hansen to an $80 million acquisition by Auris Health back in July 2016, said in prepared remarks. “I look forward to leveraging my experience in building and growing successful co...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Wall Street Beat Clinical Innovations Dune Medical Devices Inc. Globus Medical OMNIlife Science Inc. OptiScan personnel-moves SetPoint Medical Strata Skin Sciences TrueVision Systems Source Type: news

A Pill Will Protect You From Sun? No Way, FDA Says
The U.S. Food and Drug Administration on Tuesday issued warning letters to companies marketing supplements that they claim will counter the effects of the sun's harmful ultraviolet (UV) rays. (Source: WebMD Health)
Source: WebMD Health - May 23, 2018 Category: Consumer Health News Source Type: news

Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters
SAN DIEGO, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- Access Scientific, LLC announced completion of an in vivo study demonstrating the superior anti-thrombotic (i.e., anti-clotting) property of its unique intravascular catheter material, C... Devices Access Scientific, ChronoFlex, BioGUARD, POWERWAND, catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

Alcohol brand use of youth-appealing advertising and consumption by youth and adults - Padon AA, Rimal RN, Siegel M, Dejong W, Naimi TS, JernFigan DH.
BACKGROUND: Youth exposure to alcohol marketing has been shown to be an important contributor to the problem of underage drinking in the U.S. More work is needed on identifying and minimizing content with particular appeal to youth. DESIGN AND METHODS: We ... (Source: SafetyLit)
Source: SafetyLit - May 23, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
The agreement to bring a biosimilar of bevacizumab to the United States will improve patient access and affordability of this important oncology treatment MADRID, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- mAbxience, a company specialize... Biopharmaceuticals, Generics, Licensing mAbxience, Insud Pharma Group, Amneal Pharmaceuticals, bevacizumab, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
PALO ALTO, Calif., May 23, 2018 -- (Healthcare Sales & Marketing Network) -- ReCor Medical announced today that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and demonstrated a statistically significant reduction in blood pressure in hypert... Devices, Cardiology ReCor Medical, Paradise System, hypertension, Renal Denervation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

The FDA Is Warning People to Steer Clear of Sunscreen Pills
Sunscreen comes in many forms, from lotions to sprays to creams — but the Food and Drug Administration (FDA) is warning consumers to steer clear of one formula in particular: so-called sunscreen pills. The agency on Tuesday announced that it sent warnings letters to four companies claiming to make dietary supplements that can protect people from sun damage, and reminded consumers that, “There’s no pill or capsule that can replace your sunscreen.” The announcement specifically calls out four products — GliSODin Skin Nutrients’ Advanced Skin Brightening Formula, Napa Valley Bioscience&rsqu...
Source: TIME: Health - May 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Supplements Source Type: news

HRSA: Solicitation of Nominations for Membership To Serve on the National Advisory Council on the National Health Service Corps
The Health Resources and Services Administration is seeking nominations on a continuous basis to serve as members of the National Advisory Council on the National Health Service Corps (NACNHSC). Nominations should represent the areas of primary care, dental health, and mental health and demonstrate expertise in the following areas: working with underserved populations, health care policy, recruitment and retention, site administration, customer service, marketing, organizational partnerships, research, or clinical practice. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - May 23, 2018 Category: Rural Health Source Type: news

Research highlights the influence social media marketing has on children's food intake
(University of Liverpool) New research from the University of Liverpool, presented at the European Congress on Obesity today (Wednesday, May 23), highlights the negative influence that social media has on children's food intake. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 23, 2018 Category: International Medicine & Public Health Source Type: news

Despite ban, marketing of hazardous breast-milk substitutes stays rampant
In India, ironically, Nearly half the infants under six months are not exclusively breastfed a rate that has not improved substantially in two decades. (Source: The Economic Times)
Source: The Economic Times - May 23, 2018 Category: Consumer Health News Source Type: news

A Pill Will Protect You From Sun? No Way, FDA Says
The U.S. Food and Drug Administration on Tuesday issued warning letters to companies marketing supplements that they claim will counter the effects of the sun's harmful ultraviolet (UV) rays. (Source: WebMD Health)
Source: WebMD Health - May 22, 2018 Category: Consumer Health News Source Type: news

FDA Warns Kratom Makers Over Illegal Sales, Deceptive Marketing FDA Warns Kratom Makers Over Illegal Sales, Deceptive Marketing
The FDA continues its crackdown on'unscrupulous vendors'of unapproved products containing kratom, especially those making unproven medical claims.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
Chicago, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- AbelsonTaylor, the world's largest independent medical advertising agency, has hired Amanda Hartzmark as director of business development and analysis. Responsible for leading the agency's ... Personnel AbelsonTaylor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

SomaGenics Launches Its RealSeq(R)-biofluids Kit and Advances Liquid Biopsy Development With New NIH Funding for cf-miRNA NGS Technology
SANTA CRUZ, Calif., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- SomaGenics announced the launch of RealSeq®-biofluids, a next-generation sequencing (NGS) library construction kit sensitive enough to detect small RNAs from cell-free biofl... Diagnostics, Oncology, Product Launch SomaGenics, RealSeq, biofluids, Liquid Biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

A Pill to Protect You From the Sun? Don't Believe It, FDA Says
TUESDAY, May 22, 2018 -- If you think popping a pill will somehow keep your skin safe while you tan, think again. The U.S. Food and Drug Administration on Tuesday issued warning letters to companies marketing supplements that they claim will... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2018 Category: General Medicine Source Type: news

Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
PALO ALTO, Calif., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now r... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Sirtex Medical, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

New GLOBAL UNITE Reverse Fracture Shoulder Implant from DePuy Synthes Addresses Unmet Needs in Complex Shoulder Fractures
New system designed to preserve joint function and stability and promote bone healing WARSAW, Ind., May 22, 2018 -- (Healthcare Sales & Marketing Network) -- DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the... Devices, Orthopaedic, Product Launch DePuy Synthes, Johnson & Johnson, GLOBAL UNITE, Reverse Fracture Shoulder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Macquarie University Successfully Provides Overleaf Accounts to over 40,000 Students and 3,000 Staff
Overleaf, an innovative provider of scholarly writing and publishing tools, and Macquarie University Libraryhave successfully partnered to provide all Macquarie University’s students and staff with an Overleaf Pro+ account. The Macquarie University Library has provided this access via an Overleaf custom portal, allowing over 40,000 students and 3,000 staff to sign-in to, or sign-up for, an Overleaf Pro+ account which enables users to access all the features provided by the Overleaf platform. Macquarie’s researchers can use Overleaf for writing, collaboration and submission of journal papers. Additionally, lectu...
Source: News from STM - May 22, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: Editorial Featured Source Type: news

MaxQ-AI Receives CE Mark Approval for Accipio(TM)Ix Intracranial Hemorrhage Artificial Intelligence Software Platform
TEL AVIV, Israel, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- MaxQ Artificial Intelligence (MaxQ-AI), a global artificial intelligence (AI) healthcare company, today announced that it has received the CE Mark approval for its revolutionary A... Devices, Radiology, Neurology, Regulatory MaxQ-AI, Accipio, intracranial hemorrhage, CT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance
MAASTRICHT, Netherlands, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- A highly innovative software, developed by Pie Medical Imaging - PMI - B.V. (Esaote Group) will be presented at EuroPCR 2018, the world-leading course in interventional car... Devices, Interventional Cardiology Pie Medical Imaging, CAAS vFFR, Cardiovascular Angiographic Analysis Systems (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Nobles Medical Technologies II Showcases Noblestitch(TM) PFO Closure At EuroPCR
NOBLES MEDICAL TECHNOLOGIES II, INC. (NMT2) ANNOUNCES THE PRESENTATION OF ITS ITALIAN CLINICAL DATA PUBLISHED IN EUROINTERVENTION TO BE PRESENTED BY DR. FREDERICO DEMARCO PARIS, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- NMT2 announces ... Devices, Interventional Cardiology Nobles Medical Technology II, NobleStitch EL, PFO closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2018 Category: Pharmaceuticals Source Type: news

Kudos announces initial Shareable PDF results:
Kudos, the award-winning platform for managing research dissemination, has announced 6 month results of its new shareable PDF (S-PDF) service. The S-PDF provides researchers with a means to write and share a high-level overview for each of their publications, giving the broader context of their work and helping improve discoverability and understanding by a wide audience. It also provides a means for authors and participating publishers to understand the relative efficacy of a variety of platforms and channels in driving views and usage of articles, books and book chapters. The S-PDF comprises bibliographic information, a ...
Source: News from STM - May 22, 2018 Category: Databases & Libraries Authors: STM Publishing News Tags: Digital Featured Source Type: news

Pharma cos marketing medicines made by third parties to soon be liable for quality lapses flagged by CDSCO
The move is expected to check lapses in quality of medicines consumed by patients in the country, according to persons aware of the development. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 22, 2018 Category: Pharmaceuticals Source Type: news

An investigation into online videos as a source of safety hazard reports - Nasri L, Baghersad M, Gruss R, Marucchi NSW, Abrahams AS, Ehsani JP.
This study focuses on online video-ba... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Digital Marketing Intern
Department: DevelopmentType of position: Intern, paidTime Commitment: 20 hrs/weekDuration: 3 months–4 months (depending on term)Location: New York CityObjective:  The Digital Marketing internship will provide a practical learning experience to an individual interested in digital marketing / fundraising for an international nonprofit organization.  Language English (Source: MSF News)
Source: MSF News - May 21, 2018 Category: International Medicine & Public Health Authors: Rosanna Perri Source Type: news

Valeritas inks distro deal for V-Go device in Austria, Germany
Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing. Med Trust will take over the sales, marketing and distribution activities related to the V-Go wearable device in Austria and Germany, the companies reported. Get the full story at our sister site, Drug Delivery News. The post Valeritas inks distro deal for V-Go device in Austria, Germany appeared firs...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Distribution Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared
VANCOUVER, British Columbia, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S. market ... Devices, Neurology, Product Launch WAT Medical Enterprise, EmeTerm, neuromodulation, nausea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow IRVINE, Calif., May 21, 2018 -- (Healthcare Sales & Marketing Network) -- CERENOVUS, part of the Johnson & Johnson Medical Devices Compa... Devices, Interventional, Radiology, Neurology, FDA CERENOVUS, Johnson & Johnson, EMBOTRAP, Revascularization, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
New Survey Shows Nearly Two out of Three Women Believe Their Hands Make Them Look Older than Their Age1† FORT WORTH, Texas, May 21, 2018 -- (Healthcare Sales & Marketing Network) -- Nestlé Skin Health, a global leader focused on meeting the worl... Devices, Dermatology, FDA Nestlé Skin Health, Restylane Lyft, Restylane, dermal filler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news

Nabriva's pneumonia drug succeeds in late-stage study
(Reuters) - Nabriva Therapeutics Plc's pneumonia drug for adults met the main goal of a late-stage study, the company said on Monday, putting it on track to file a marketing application with U.S. regulators later this year. (Source: Reuters: Health)
Source: Reuters: Health - May 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Agricultural Trade Liberalization Undermined Food Security
Africa has been transformed from a net food exporter into a net food importer, while realizing only a small fraction of its vast agricultural potential. Credit: Busani Bafana/IPSBy Jomo Kwame Sundaram and Anis ChowdhuryKUALA LUMPUR AND SYDNEY, May 21 2018 (IPS)Agriculture is critical for achieving the Sustainable Development Goals (SDGs). As the Food and Agriculture Organization (FAO) notes, ‘From ending poverty and hunger to responding to climate change and sustaining our natural resources, food and agriculture lies at the heart of the 2030 Agenda.’ For many, the answer to poverty and hunger is to accelerate e...
Source: IPS Inter Press Service - Health - May 21, 2018 Category: International Medicine & Public Health Authors: Jomo Kwame Sundaram and Anis Chowdhury Tags: Aid Climate Change Development & Aid Economy & Trade Featured Food & Agriculture Food Sustainability Global Global Governance Headlines Health Inequity Labour Natural Resources Poverty & SDGs TerraViva United Nations Trade Source Type: news

Executive Committee Minutes, April 10, 2018
Participants: Peter Elias, John Grohol, Sarah Krüg, Janice McCallum, Burt Rosen, Danny Sands, Joe Ternullo, Sue Woods Minutes from March 13, 2018 meeting approved Announcements Danny: A patient ambassador orientation guide was developed (with help from participating patient advisors & others)  for the annual meeting of the Society of General Internal Medicine (SGIM). It was suggested we adopt something similar for SPM. Joe- Conference Forum—Joe will write summary notes of this 3-day meeting. He hopes some sponsorships for SPM will result from his participation at the Conference Forum. Sue: She h...
Source: Society for Participatory Medicine - May 20, 2018 Category: General Medicine Authors: janicemc Tags: Executive Minutes Exec Committee Executive Committee Minutes Meeting Minutes Source Type: news

Executive Committee Minutes, March 13, 2018
Participants: Peter Elias, John Grohol, Janice McCallum, Burt Rosen,Danny Sands, Joe Ternullo, Sue Woods Minutes from February Executive Board Meeting approved.   Announcements / HIMSS Comments SPM had a good number of members attending the HIMSS18 conference. We awarded patient travel funds to about 8 people. Danny suggested that we offer more guidance to patient award recipients next time to prepare them for the massive HIMSS annual conference. Janice pointed to a post by HISTalk that offered suggestions on how to prepare patient attendees for HIMSS. [Note that another SPM member posted HIStalk post on Connect, whic...
Source: Society for Participatory Medicine - May 20, 2018 Category: General Medicine Authors: janicemc Tags: Executive Minutes News Exec Committee Executive Committee Minutes Meeting Minutes Source Type: news

Executive Committee Minutes, February 13, 2018
Participants: Peter Elias, John Grohol, Sarah Krüg, Janice McCallum, Burt Rosen, Danny Sands, Joe Ternullo, Sue Woods Announcements / Comments Joe announced that he has a free pass available for HIMSS, which he procured as part of our ongoing efforts to strengthen our relationship with HIMSS. [Subsequently given to SPM member.] Danny announced that Matthew Holt has raised $15,000 for HIMSS travel fund. Note, the procedure this year will allow non-members to apply, but $50 of non-member travel award will be applied toward a membership.  Any leftover funds will stay in the SPM travel fund. Distribution of the ...
Source: Society for Participatory Medicine - May 20, 2018 Category: General Medicine Authors: janicemc Tags: Executive Minutes News Executive Committee Minutes Meeting Minutes Source Type: news

Board Meeting Minutes, March 27, 2018
Participants:  Geri Baumblatt, Dave DeBronkart, Judy Danielson, Peter Elias, Nancy Finn, John Grohol, Matthew Holt, Sarah Krüg, Janice McCallum, Jan Oldenburg, Parika (Pinky) Petaipimol, Burt Rosen, Danny Sands, Linda Stotsky, Joe Ternullo, Sue Woods Approve minutes from last full board meeting—Janice McCallum Minutes from February 27, 2018 approved. Treasurer’s Report (financial and membership numbers)–John Grohol Danny asked about a decline in funds, which John explained was due to outlay for HIMSS travel funds that have outstanding invoices from sponsors. Related to travel funds, HIMSS Health...
Source: Society for Participatory Medicine - May 20, 2018 Category: General Medicine Authors: janicemc Tags: Board Minutes Board Meeting Meeting Minutes Source Type: news

Board Meeting Minutes, February 27, 2018
Participants:  Geri Baumblatt, Dave DeBronkart, Judy Danielson, Dave Dolton, Peter Elias, John Grohol, Matthew Holt, Sarah Krüg, Janice McCallum, Jan Oldenburg, Burt Rosen, Danny Sands, Linda Stotsky, Joe Ternullo, Sue Woods and Vera Rulon. Approve minutes from last full board meeting—Janice McCallum Minutes from January 23, 2018 approved. Janice pointed out that with change to procedure in posting meeting minutes, we will need to move finalized minutes to a folder that is viewable by anyone.  Also need to change the link in Where to Find What at S4PM and tell Danny v Leeuwen to change link in newslet...
Source: Society for Participatory Medicine - May 20, 2018 Category: General Medicine Authors: janicemc Tags: Board Minutes Board Meeting Meeting Minutes Source Type: news